hrs-7085
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 5, 2022 (NCT05638347)
Timeline
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07229950 | Phase 2 | Dec 31, 2025 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
| NCT06175949 | Phase 1 | Dec 31, 2023 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
| NCT05638347 | Phase 1 | Dec 5, 2022 | Atridia Pty Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Suzhou Suncadia Biopharmaceuticals Co., Ltd. | For profit | 2 | 2 | 2 | 2023 |
| Atridia Pty Ltd. | For profit | 1 | 1 | 1 | 2022 |
2 organizations
Page 1 / 1